These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12886175)

  • 61. Triple assessment of breast lump.
    Ahmed I; Nazir R; Chaudhary MY; Kundi S
    J Coll Physicians Surg Pak; 2007 Sep; 17(9):535-8. PubMed ID: 17903400
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of high frequency ultrasonography in the evaluation of palpable breast masses in Chinese women: alternative to mammography?
    Yang WT; Mok CO; King W; Tang A; Metreweli C
    J Ultrasound Med; 1996 Sep; 15(9):637-44. PubMed ID: 8866446
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: an analysis for Austria.
    Gruber R; Walter E; Helbich TH
    Eur J Radiol; 2010 Jun; 74(3):519-24. PubMed ID: 19427153
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of simulators to explore specialty recommendation for a palpable breast mass.
    Laufer S; Ray RD; D'Angelo AL; Jones GF; Pugh CM
    Am J Surg; 2015 Oct; 210(4):618-23. PubMed ID: 26198334
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer.
    Chen VK; Arguedas MR; Kilgore ML; Eloubeidi MA
    Am J Gastroenterol; 2004 Nov; 99(11):2223-34. PubMed ID: 15555006
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred?
    Park YM; Kim EK; Lee JH; Ryu JH; Han SS; Choi SJ; Lee SJ; Yoon HK
    Acta Radiol; 2008 Dec; 49(10):1104-11. PubMed ID: 18855166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses.
    Dwamena BA; Kloos RT; Fendrick AM; Gross MD; Francis IR; Korobkin MT; Shapiro B
    J Nucl Med; 1998 Apr; 39(4):707-12. PubMed ID: 9544685
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Cost-effectiveness of percutaneous core needle breast biopsy (CNBB) versus open surgical biopsy (OSB) of nonpalpable breast lesions: metaanalysis and cost evaluation for German-speaking countries].
    Gruber R; Bernt R; Helbich TH
    Rofo; 2008 Feb; 180(2):134-42. PubMed ID: 18058636
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
    Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
    J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Accuracy of fine-needle aspiration biopsy in diagnosis of palpable breast masses: two-year results of a university-affiliated community hospital.
    Benedetto JC; Allora VG; Wyatt LL
    J Am Osteopath Assoc; 1993 May; 93(5):585-8. PubMed ID: 8314720
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Palpable solid breast masses: retrospective single- and multimodality evaluation of 201 lesions.
    van Dam PA; Van Goethem ML; Kersschot E; Vervliet J; Van den Veyver IB; De Schepper A; Buytaert P
    Radiology; 1988 Feb; 166(2):435-9. PubMed ID: 3275983
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis.
    Rimm DL; Stastny JF; Rimm EB; Ayer S; Frable WJ
    Cancer; 1997 Feb; 81(1):51-6. PubMed ID: 9100542
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An analysis of fine needle aspiration versus core needle biopsy in clinically palpable breast lesions: a report on the predictive values and a cost comparison.
    Nagar S; Iacco A; Riggs T; Kestenberg W; Keidan R
    Am J Surg; 2012 Aug; 204(2):193-8. PubMed ID: 22464444
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
    Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
    Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Costs and benefits of breast cancer diagnosis.
    Leivonen M
    Acta Oncol; 1987; 26(4):257-60. PubMed ID: 3120757
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies.
    Allen MW; Hendi P; Schwimmer J; Bassett L; Gambhir SS
    Q J Nucl Med; 2000 Jun; 44(2):168-85. PubMed ID: 10967626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.